SCHEMBL6804404

SCHEMBL6804404

CSc1ccc(-c2ccccc2C(=O)Nc2ccc3c(c2)CCN3C(=O)Cc2cccc(N)n2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EIF2AK3 Q9NZJ5 3/20 0.44
RIPK1 Q13546 2/20 0.44
CREBBP Q92793 1/20 0.41
MAPT P10636 2/20 0.40
KMT2A Q03164 2/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
HSD17B10 Q99714 1/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
NPY2R P49146 3/20 0.39
OPRL1 P41146 1/20 0.38
AVPR2 P30518 2/20 0.38
AVPR1A P37288 2/20 0.38
OXTR P30559 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6662998 0.92 EIF2AK3 (0.42) EIF2AK3RIPK1CREBBPMAPTKMT2A
SCHEMBL6803357 0.91 EIF2AK3 (0.46) EIF2AK3RIPK1CREBBPMAPTNPC1
Hydrochloric Acid SCHEMBL6804708 0.91 EIF2AK3 (0.45) EIF2AK3RIPK1CREBBPMAPTNPC1
SCHEMBL6803323 0.90 EIF2AK3 (0.43) EIF2AK3RIPK1CREBBPMAPTKMT2A
SCHEMBL6804796 0.89 GAA (0.46) EIF2AK3RIPK1CREBBPMAPTKMT2A
SCHEMBL6800625 0.89 EIF2AK3 (0.43) EIF2AK3RIPK1CREBBPMAPTHTR2C
SCHEMBL6805404 0.88 EIF2AK3 (0.49) EIF2AK3RIPK1CREBBPMAPTKMT2A
SCHEMBL6806327 0.88 EIF2AK3 (0.41) EIF2AK3RIPK1CREBBPMAPTKMT2A
SCHEMBL6667700 0.88 SMO (0.49) EIF2AK3RIPK1MAPTKDM4EALDH1A1
Hydrochloric Acid SCHEMBL6805924 0.87 SMO (0.49) EIF2AK3RIPK1MAPTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040157866-A1 Amide compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040157866-A1 Amide compounds APOB, NR1H2, NR1H3 EIF2AK3 2638/4885RIPK1 3523/4885CREBBP 1901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.